Cessatech A S

Cessatech is a pivotal-stage paediatric biotech company developing first-in-class specialty hospital medicines for children, focused on high-impact unmet needs in acute and emergency care. The company’s lead program, CT001, is advancing toward near-term commercialization. Cessatech operates a capital-efficient, partnership-driven model, combining a lean, experienced team with best-in-class partners for development, manufacturing and commercial execution across key markets. Headquartered in Hellerup, Denmark, Cessatech is led by a seasoned leadership team with a strong track record in drug development and product launches in Europe, the US and Asia.